Home › Lipoid Nephrosis › Georgia › Atlanta
Lipoid Nephrosis clinical trials in Atlanta, GA
4 studies for Lipoid Nephrosis are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Emory Children's Center- Site Number : 8400020, Atlanta
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2
- Fides Clinical Research, Atlanta
NEPTUNE Match Study
Recruiting
- Emory University Hospital - Children's Hospital of Atlanta, Atlanta
Nephrotic Syndrome Study Network
RecruitingObservational study
- Emory University and Children's Healthcare of Atlanta, Atlanta
Lipoid Nephrosis trials in other cities
- Philadelphia, PA5 studies
- Queens, NY5 studies
- Ann Arbor, MI5 studies
- Durham, NC4 studies
- Houston, TX4 studies
- Los Angeles, CA3 studies
- Seattle, WA3 studies
- Kansas City, MO3 studies
- New York City, NY3 studies
- Cleveland, OH3 studies
- Chicago, IL3 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Multiple Myeloma41 studies
- Breast Cancer41 studies
- Prostate Cancer32 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Obesity25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.